Evernorth Puts Sept. 30 XRP Holdings at $342 Million After Impairment
An unaudited Form 10-Q filed Nov. 13 put the balance at $341.89 million against $846.58 million in historical cost.

Evernorth Holdings Inc. recorded $271.04 million in XRP impairment charges through Sept. 30, including $6.89 million in the third quarter, while its quarter-end holdings carried at $341.89 million.
Evernorth filed an unaudited Form 10-Q on Nov. 13. At Sept. 30, the company held 346,284,972 XRP, with historical cost of $846.58 million and a carrying value of $341.89 million. The figures cover the period before Evernorth completed its business combination on Oct. 9.
The first-half impairment tally was $264.1 million, before the additional $6.89 million charge in the third quarter brought the nine-month total to $271.04 million. After the transaction closed, Evernorth held about 473 million XRP, and its shares began trading on Nasdaq under XRPN on Oct. 12. The business-combination close and post-close XRP treasury put the September snapshot in context: it is not the later treasury total.
Evernorth treats XRP as an indefinite-lived intangible asset, measured at cost less accumulated impairment. Its test for each lot uses the lowest observable intraday price on Coinbase since acquisition. After a write-down, the reduced value becomes the new cost basis and is not marked upward if XRP’s price later rises. That policy means the carrying value reflects the impairment history for the holdings, rather than a current market quote.
For the nine months, Evernorth recorded a $32.87 million net loss and a $240.31 million gain from changes in the fair value of refundable investor advances. In the third quarter, it recorded $155.26 million in net income alongside a $162.83 million gain on those advances. The two periods show how the remeasurement of investor advances affected reported earnings alongside the XRP impairment.
Evernorth had $1.72 million in net cash used in operating activities during the nine months. Its cash-flow reconciliation listed impairment and advance remeasurement among the adjustments to net loss. The impairment was an accounting write-down; it did not equal a comparable operating cash outflow for the period.